Topazian HM, Schmit N, Gerard-Ursin I, Charles GD, et al. Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis. Vaccine 2023 Apr 18:S0264-410X(23)00394-8. doi: 10.1016/j.vaccine.2023.
PMID: 37080831